GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,485.60p
   
  • Change Today:
      24.60p
  • 52 Week High: 2,263.00
  • 52 Week Low: 1,296.00
  • Currency: UK Pounds
  • Shares Issued: 4,094.68m
  • Volume: 7,774,368
  • Market Cap: £60,831m
  • RiskGrade: 129

Financial Analysis

Select chart: EPS | Dividend | Revenue

Key Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-18 30,821.00 4,800.00 119.40p 15.6 2.2 +7% 80.00p 4.3%
31-Dec-19 33,754.00 6,221.00 123.90p 17.9 4.5 +4% 80.00p 3.6%
31-Dec-20 34,099.00 6,968.00 115.90p 14.5 n/a -6% 80.00p 4.8%
31-Dec-21 24,969.00 3,599.00 113.20p 17.7 n/a -2% 100.00p 5.0%
31-Dec-22 29,324.00 5,628.00 139.70p 10.3 0.4 +23% 44.00p 3.1%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-23 29,064.51 8,149.61 145.44p 10.2 2.5 +4% 56.04p 0.0%
31-Dec-24 30,889.31 8,757.76 154.69p 9.6 1.5 +6% 59.94p 0.0%
31-Dec-25 32,786.49 9,455.51 170.19p 8.7 0.9 +10% 64.15p 0.0%

Copyright © 2023 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest 15.61 10.29 15.21 0.70

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

GSK Market Data

Currency UK Pounds
Share Price 1,485.60p
Change Today 24.60p
% Change 1.68 %
52 Week High 2,263.00
52 Week Low 1,296.00
Volume 7,774,368
Shares Issued 4,094.68m
Market Cap £60,831m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
62.38% below the market average62.38% below the market average62.38% below the market average62.38% below the market average62.38% below the market average
72.88% above the sector average72.88% above the sector average72.88% above the sector average72.88% above the sector average72.88% above the sector average
Price Trend
36.23% below the market average36.23% below the market average36.23% below the market average36.23% below the market average36.23% below the market average
36.51% above the sector average36.51% above the sector average36.51% above the sector average36.51% above the sector average36.51% above the sector average
Income
63.68% above the market average63.68% above the market average63.68% above the market average63.68% above the market average63.68% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
51.76% below the market average51.76% below the market average51.76% below the market average51.76% below the market average51.76% below the market average
75.61% below the sector average75.61% below the sector average75.61% below the sector average75.61% below the sector average75.61% below the sector average

What The Brokers Say

Strong Buy 2
Buy 6
Neutral 14
Sell 1
Strong Sell 2
Total 25
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q4 Q3
Ex-Div 23-Feb-23 17-Nov-22
Paid 13-Apr-23 12-Jan-23
Amount 13.75p 13.75p

Trades for 07-Feb-2023

Time Volume / Share Price
16:45 153 @ 1,485.40p
16:45 153 @ 1,485.40p
16:45 6,466 @ 1,485.40p
16:45 6,466 @ 1,485.40p
16:35 1,000 @ 1,485.60p

GSK Key Personnel

CEO Emma Walmsley
CFO Iain Mackay

Top of Page